Dr. Elwyn Clement Cabebe, MD

Dr. Cabebe practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Cabebe's NPI, 1821067281, was assigned on March 16, 2006. Dr. Cabebe graduated from The Robert Larner, M.D. College of Medicine in 2002. Dr. Cabebe's California license number on file is A84778.

Dr. Cabebe's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Cabebe's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Cabebe is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Cabebe to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Cabebe's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cabebe practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Cabebe's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Cabebe is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dr. Cabebe has a license on file in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Cabebe treats.

CMS data shows 3,100 Medicare services from Dr. Cabebe across 6 procedure codes in 2024, for 843 Medicare patients. Medicare paid $279,021 for them.

CMS counts 843 Medicare patients who saw Dr. Cabebe in 2024. The largest group is 75 to 84, with 357 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cabebe's median patient age at 68, with 68% women.

In 2024, Dr. Cabebe wrote 311 Medicare Part D claims for 101 patients. 67% of them were for generic drugs. CMS names the drug for 171 of them, across 8 drugs with 11 or more claims each, at $228,198 in total drug cost. In 2023, CMS named 122 claims across 4 drugs.

Dr. Cabebe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cabebe as offering telehealth.

Dmand AI links 13 papers to Dr. Cabebe, published from 2011 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Angiogenesis Inhibitors and Antibodies, Monoclonal. Dr. Cabebe has published most often in Lung. Dr. Cabebe's most frequent co-authors are Heather Ann Wakelee, MD, Michael F. Gensheimer, MD and Vincent K. Lam, MD.

CMS Open Payments shows 187 general payments to Dr. Cabebe from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $826.

Dmand AI lists 2 awards for Dr. Cabebe, most recently Checkbook Top Doc in 2013.

Dr. Cabebe graduated from The Robert Larner, M.D. College of Medicine in 2002. Dr. Cabebe is a member of ACP and ASCO.

Dr. Cabebe is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.